NVCT - Nuvectis Pharma, Inc. News

Nuvectis Pharma Q2 EPS $(0.30) Misses $(0.26) Estimate

Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.30) per share which missed the analys

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

FORT LEE, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" o

Wall Street Analysts Predict a 56.41% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know

The mean of analysts' price targets for Nuvectis Pharma (NVCT) points to a 56.4% upside in the stock

Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China

First global approval of a once-daily, orally administered, Complement Factor B inhibitor Approval b

Nuvectis Pharma's Ciprocopan Receives Marketing Approval From National Medicinal Products Administra

Nuvectis Pharma, Inc. (NASDAQ:NVCT) ("Nuvectis" or the "Company"), a clinical-stage

Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Prev

Fort Lee, NJ, July 23, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or

Ryanair Posts Weak Q1 Results, Joins HDFC Bank And Other Big Stocks Moving Lower In Monday’s Pre-Mar

US stock futures higher with Nasdaq 100 up 150 points. Ryanair (RYAAY) shares fall after weak Q1 res

newsfilecorp.com

StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Stro

New report covers Nuvectis Pharma (NASDAQ: NVCT) as the company transitions from a single-drug oncol

Wall Street Analysts See a 61.46% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This H

The consensus price target hints at a 61.5% upside potential for Nuvectis Pharma (NVCT). While empir

IBM To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all rating

Roth Capital Maintains Buy on Nuvectis Pharma, Raises Price Target to $33

Roth Capital analyst Jonathan Aschoff maintains Nuvectis Pharma (NASDAQ:NVCT) with a Buy and rais

What Makes Nuvectis Pharma, Inc. (NVCT) a Strong Momentum Stock: Buy Now?

Does Nuvectis Pharma, Inc. (NVCT) have what it takes to be a top stock pick for momentum investors?

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market s

Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big

US stock futures up, Dow futures gain 100+ points. Concentrix Corp (CNXC) shares down 24% after weak

Why AeroVironment Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket

AeroVironment, Inc. (NASDAQ: AVAV) jumped 21.4% in pre-market trading after reporting strong financi

Reported Earlier, Nuvectis Pharma Prices $100M Public Offering Of 5M Common Shares At $20.00 Per Sha

Nuvectis intends to use the net proceeds from the offering to continue to advance the development pr

Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock

FORT LEE, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical s

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market

Nuvectis Pharma Commences Common Stock Offering; Terms Undisclosed

Nuvectis Pharma, Inc. (NASDAQ:NVCT), a clinical stage biopharmaceutical company focused on the devel

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

FORT LEE, NJ, June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical sta

What Makes Nuvectis Pharma (NVCT) a New Buy Stock

Nuvectis Pharma (NVCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's reg

Nuvectis Pharma Jumps 20% To 52-Week High — Here's Why NVCT Stock Is Trending

NVCT stock jumped after Nuvectis expanded its pipeline through a licensing deal with Haisco.

HC Wainwright & Co. Maintains Buy on Nuvectis Pharma, Raises Price Target to $39

HC Wainwright & Co. analyst Joseph Pantginis maintains Nuvectis Pharma (NASDAQ:NVCT) with a B

seekingalpha.com

Nuvectis Pharma, Inc. (NVCT) Discusses Strategic In-Licensing Deal and Expansion Into Complement-Med

reuters.com

Nuvectis gains two experimental drugs in licensing deal with China's Haisco

Nuvectis Pharma said on Monday it had licensed exclusive rights outside China to two experimental dr

Nuvectis Pharma Strikes License Agreement With Haisco Pharmaceutical Group For Exclusive Ex-China Ri

Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage

Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Hais

Fort Lee, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or

HC Wainwright & Co. Maintains Buy on Nuvectis Pharma, Raises Price Target to $13

HC Wainwright & Co. analyst Joseph Pantginis maintains Nuvectis Pharma (NASDAQ:NVCT) with a B

Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet

The mean of analysts' price targets for Nuvectis Pharma (NVCT) points to a 57% upside in the stock.

Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conferenc

Fort Lee, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or t

Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 62.5% in Nu

Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights

FORT LEE, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Can

Fort Lee, NJ, March 31, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or

Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights

FORT LEE, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" o

defenseworld.net

Nuvectis Pharma (NASDAQ:NVCT) Trading Up 5.8% – Should You Buy?

Nuvectis Pharma, Inc. (NASDAQ: NVCT - Get Free Report) shot up 5.8% on Wednesday. The company traded

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session